Publication: Fatal Eastern Equine Encephalitis in a Patient on Maintenance Rituximab: A Case Report
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford University Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Solomon, Isaac H., Pedro D. S. C. Ciarlini, Sandro Santagata, Asim A. Ahmed, Umberto De Girolami, Sashank Prasad, and Shibani S. Mukerji. 2017. “Fatal Eastern Equine Encephalitis in a Patient on Maintenance Rituximab: A Case Report.” Open Forum Infectious Diseases 4 (1): ofx021. doi:10.1093/ofid/ofx021. http://dx.doi.org/10.1093/ofid/ofx021.
Research Data
Abstract
Abstract A 63-year-old woman on rituximab maintenance for follicular lymphoma presented with headaches, vomiting, and fever, and was diagnosed with eastern equine encephalomyelitis by cerebrospinal fluid polymerase chain reaction. Eastern equine encephalomyelitis immunoglobulin (Ig)G/IgM remained negative due to rituximab treatment, and magnetic resonance imaging showed minimal abnormalities, making this a diagnostically challenging case. Despite therapy with intravenous Ig, the patient rapidly declined and died on hospital day 12. Autopsy revealed perivascular and parenchymal chronic inflammation, with an absence of B lymphocytes, and virally infected neurons throughout the central nervous system.
Description
Other Available Sources
Keywords
Editor's Choice, arbovirus, eastern equine encephalitis, immunosuppressed, neuroinvasive, rituximab
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service